King Pharmaceuticals Inc.

(NYSE:KG)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Assets
Current Assets
Cash & Equivalents 1,231,451 1,095,549 826,582 20,009
Restricted Cash
Marketable Securities 72,618 99,030 590,696 1,346,115
Accounts Receivable 168,597 169,040 186,787 183,664
Loans Receivable
Other Receivable 20,175
Receivables 168,597 169,040 186,787 203,839
Raw Materials 109,877 115,657 125,514 129,781
Work in Progress 30,065 32,637 24,378 27,590
Purchased Components
Finished Goods 59,465 66,879 68,952 61,324
Other Inventories
Inventories Adjustments and Allowances -107,016 -110,274 -108,283 -108,387
Inventories 92,391 104,899 110,561 110,308
Prepaid Expenses 55,396 39,216 40,311 39,245
Current Deferred Income Taxes 79,651 94,171 95,836 100,138
Other Current Assets
Total Current Assets 1,700,104 1,601,905 1,850,773 1,819,654
Land and Improvements 12,072
Building and Improvements 123,063
Machinery Furniture and Equipment 213,522
Construction in Progress 62,638
Other Fixed Assets 411,368 418,641 418,991
Total Fixed Assets 411,368 418,641 418,991 411,295
Gross Fixed Assets 411,368 418,641 418,991 411,295
Accumulated Depreciation and Depletion 154,202 154,202 154,202 154,202
Net Fixed Assets 257,166 264,439 264,789 257,093
Intangibles 655,472 674,521 733,847 780,974
Cost in Excess 129,150 129,150 129,150 129,150
Non Current Deferred Income Taxes 357,418 364,700 351,983 343,700
Other Non Current Assets 412,445 422,739 88,827 96,251
Total Non Current Assets 1,811,651 1,855,549 1,568,596 1,607,168
Total Assets 3,511,755 3,457,454 3,419,369 3,426,822
Liabilities
Current Liabilities
Accounts Payable 68,900 65,197 59,342 76,481
Notes Payable
Short Term Debt
Accrued Expenses 226,508 278,564 293,304 376,604
Accrued Liabilities
Deferred Revenues
Current Deferred Income Tax Liabilities
Other Current Liabilities 22,674 17,149 17,180
Total Current Liabilities 318,082 360,910 369,826 453,085
Non Current Liabilities
Long Term Debt 400,000 400,000 400,000 400,000
Capital Lease Obligations
Deferred Income Tax Liabilities
Other Non Current Liabilities 60,810 61,947 62,331 62,980
Minority Interest Liabilities
Preferred Securities of Subsidiary Trust Liabilities
Preferred Equity Outside Stock Equity
Total Non Current Liabilities 778,892 822,857 832,157 916,065
Total Liabilities 460,810 461,947 462,331 462,980
Shareholders' Equity
Preferred Stock Equity
Common Stock Equity 2,732,863 2,634,597 2,587,212 2,510,757
Common Par
Additional Paid in Capital 1,305,057 1,297,974 1,290,079 1,283,440
Cumulative Translation Adjustment 1,957
Retained Earnings 1,440,764 1,356,014 1,312,993 1,225,360
Treasury Stock
Other Equity Adjustments -12,958 -19,391 -15,860
Total Capitalization 3,132,863 3,034,597 2,987,212 2,910,757
Cash Flow 434,145 308,857 330,621 358,901
Working Capital 1,382,022 1,240,995 1,480,947 1,366,569
Free Cash Flow 296,428 198,380 79,569 227,668
Invested Capital 3,132,863 3,034,597 2,987,212 2,910,757
Total Equity 2,732,863 2,634,597 2,587,212 2,510,757
Total Liabilities and Stock Equity 3,511,755 3,457,454 3,419,369 3,426,822